Scott Randal W
Insider CIK 1337801 · GHDX Executive Chairman, Director · NVTA Executive Chairman, Director, 10% owner · TLIS Director · BBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-05-15 | 2026-05-19 | 10,000 | — | $0 | 21,501 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-15 | 2026-05-19 | 6,200 | $66.69 | $413.5K | 15,389 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-05-15 | 2026-05-19 | 10,000 | $16.75 | $167.5K | 21,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-15 | 2026-05-19 | 1,512 | $68.23 | $103.2K | 11,789 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-15 | 2026-05-19 | 2,088 | $67.53 | $141.0K | 13,301 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-05-15 | 2026-05-19 | 200 | $69.12 | $13.8K | 11,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2026-02-17 | 2026-02-18 | 10,000 | — | $0 | 31,501 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-17 | 2026-02-18 | 3,307 | $75.93 | $251.1K | 11,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-17 | 2026-02-18 | 4,793 | $75.57 | $362.2K | 14,896 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2026-02-17 | 2026-02-18 | 1,900 | $74.34 | $141.2K | 19,689 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2026-02-17 | 2026-02-18 | 10,000 | $16.75 | $167.5K | 21,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise deriv | 2025-11-17 | 2025-11-19 | 10,000 | — | $0 | 41,501 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 6,199 | $66.89 | $414.7K | 11,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 3,801 | $66.25 | $251.8K | 17,788 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | M Exercise | 2025-11-17 | 2025-11-19 | 10,000 | $16.75 | $167.5K | 21,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 11,589 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-06-04 | 2024-06-05 | 1,500 | $31.30 | $47.0K | 4,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 800 | $28.68 | $22.9K | 5,700 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 200 | $29.48 | $5.9K | 5,500 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-03-01 | 2024-03-05 | 2,500 | $34.00 | $85.0K | 6,500 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-12-18 | 2023-12-20 | 2,000 | $40.00 | $80.0K | 9,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 1,500 | $30.00 | $45.0K | 11,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-12-01 | 2023-12-05 | 1,000 | $28.50 | $28.5K | 12,500 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2023-09-05 | 2023-09-07 | 2,500 | $30.00 | $75.0K | 13,500 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-06-21 | 2023-06-23 | 51,501 | — | $0 | 51,501 | SEC↗ |
| TLIS Talis Biomedical Corp | A Award deriv | 2023-06-09 | 2023-06-12 | 95,000 | — | $0 | 95,000 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2023-04-27 | 2023-05-01 | 86,705 | — | $0 | 86,705 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2023-04-27 | 2023-05-01 | 28,901 | — | $0 | 28,901 | SEC↗ |
| NVTA Invitae Corp | A Award | 2023-04-27 | 2023-05-01 | 70,422 | — | $0 | 161,222 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2022-07-16 | 2022-07-19 | 4,275 | — | $0 | 4,275 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2022-07-16 | 2022-07-19 | 22,730 | — | $0 | 22,730 | SEC↗ |
| NVTA Invitae Corp | A Award | 2022-07-16 | 2022-07-19 | 45,325 | — | $0 | 82,325 | SEC↗ |
| NVTA Invitae Corp | A Award | 2022-07-16 | 2022-07-19 | 8,475 | — | $0 | 90,800 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| TLIS Talis Biomedical Corp | A Award deriv | 2022-06-10 | 2022-06-13 | 95,000 | — | $0 | 95,000 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| TLIS Talis Biomedical Corp | P Buy | 2021-05-17 | 2021-05-18 | 11,000 | $10.11 | $111.2K | 20,000 | SEC↗ |
| TLIS Talis Biomedical Corp | P Buy | 2021-05-14 | 2021-05-18 | 9,000 | $10.16 | $91.4K | 9,000 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion deriv | 2021-02-17 | 2021-02-19 | 478,402 | — | $0 | 0 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion deriv | 2021-02-17 | 2021-02-19 | 432,749 | — | $0 | 0 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,076,643 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2021-02-17 | 2021-02-18 | 16,000 | $62.50 | $1.00M | 21,000 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion | 2021-02-17 | 2021-02-19 | 334,546 | — | $0 | 1,087,443 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion | 2021-02-17 | 2021-02-19 | 752,897 | — | $0 | 752,897 | SEC↗ |
| TLIS Talis Biomedical Corp | P Buy | 2021-02-17 | 2021-02-19 | 312,500 | $16.00 | $5.00M | 312,500 | SEC↗ |
| TLIS Talis Biomedical Corp | C Conversion | 2021-02-17 | 2021-02-19 | 302,621 | — | $0 | 1,390,064 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-23 | 2020-06-25 | 101,223 | — | $0 | 101,223 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2019-08-26 | 2019-08-27 | 28,301 | $24.82 | $702.4K | 3,450,669 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2019-08-26 | 2019-08-27 | 11,699 | $24.02 | $281.0K | 3,478,970 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2019-05-28 | 2019-05-30 | 30,000 | $17.60 | $528.0K | 3,490,669 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2019-05-02 | 2019-05-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2019-02-25 | 2019-02-27 | 1,000 | $19.66 | $19.7K | 3,520,669 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2019-02-25 | 2019-02-27 | 29,000 | $19.08 | $553.3K | 3,521,669 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2018-06-22 | 2018-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | P Buy | 2018-04-02 | 2018-04-02 | 44,444 | $4.50 | $200.0K | 3,550,669 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2017-05-02 | 2017-05-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | P Buy | 2016-11-22 | 2016-11-22 | 66,666 | $6.00 | $400.0K | 3,506,225 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 15,715,788 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 3,921,568 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 1,000,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion | 2015-02-18 | 2015-02-18 | 3,439,559 | — | $0 | 3,439,559 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-07-11 | 2012-07-12 | 14,700 | $34.79 | $511.4K | 1,185,417 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-07-11 | 2012-07-12 | 300 | $35.52 | $10.7K | 1,185,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-07-10 | 2012-07-12 | 200 | $36.65 | $7.3K | 1,200,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-07-10 | 2012-07-12 | 14,800 | $35.96 | $532.2K | 1,200,317 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-06-12 | 2012-06-13 | 15,000 | $33.31 | $499.7K | 1,215,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-06-11 | 2012-06-13 | 14,400 | $33.74 | $485.9K | 1,230,717 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-06-11 | 2012-06-13 | 600 | $34.56 | $20.7K | 1,230,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-05-11 | 2012-05-14 | 5,620 | $30.85 | $173.4K | 1,247,297 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-05-11 | 2012-05-14 | 2,180 | $31.39 | $68.4K | 1,245,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-05-11 | 2012-05-14 | 7,200 | $30.00 | $216.0K | 1,252,917 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-05-10 | 2012-05-14 | 14,600 | $29.92 | $436.8K | 1,260,517 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-05-10 | 2012-05-14 | 400 | $30.29 | $12.1K | 1,260,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-04-11 | 2012-04-12 | 10,000 | $28.38 | $283.8K | 1,275,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-04-10 | 2012-04-12 | 9,169 | $28.75 | $263.6K | 1,285,948 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-04-10 | 2012-04-12 | 831 | $29.48 | $24.5K | 1,285,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-03-13 | 2012-03-14 | 15,000 | $31.12 | $466.8K | 1,295,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-03-12 | 2012-03-14 | 15,000 | $30.98 | $464.7K | 1,310,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | F Tax w/h | 2012-02-15 | 2012-02-17 | 629 | $28.97 | $18.2K | 1,325,117 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-02-10 | 2012-02-13 | 10,000 | $26.25 | $262.5K | 1,325,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-02-10 | 2012-02-14 | 10,000 | $26.25 | $262.5K | 1,325,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-02-09 | 2012-02-13 | 10,000 | $26.10 | $261.0K | 1,335,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-02-09 | 2012-02-14 | 10,000 | $26.10 | $261.0K | 1,335,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2012-02-05 | 2012-02-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award deriv | 2012-02-05 | 2012-02-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-02-05 | 2012-02-07 | 4,600 | — | $0 | 1,345,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | A Award | 2012-02-05 | 2012-02-08 | 4,600 | — | $0 | 1,345,746 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-01-11 | 2012-01-12 | 9,900 | $27.55 | $272.7K | 1,341,246 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-01-11 | 2012-01-12 | 100 | $28.23 | $2.8K | 1,341,146 | SEC↗ |
| GHDX GENOMIC HEALTH INC | S Sale | 2012-01-10 | 2012-01-12 | 10,000 | $27.35 | $273.5K | 1,351,146 | SEC↗ |